Pfizer is wielding its power over governments and dictating the course of action to their financial advantage. The conflicts of interest of the FDA committee alone is egregious. Pfizer has cultivated sponsorships of the media, too. This enormous amount of power and control is spine-chilling.
- Pfizer Reserves the Right to Silence Governments – Pfizer is silencing the governments through its contracts. It has forced countries not to talk about the deals they strike for shots.
- Pfizer Controls Distribution of Shots – Pfizer controls the donations of the shots, not the country that buys them. Pfizer will decide where the shots go.
- Pfizer Secured an “IP Waiver” for Itself – If Pfizer is accused of intellectual property theft, governments will pay not the company.
- Private Arbitrators, not Public Courts, Decide Disputes in Secret – If there are disputes, private arbitrators and not public courts will decide on them
- Pfizer Can Go After State Assets – Pfizer can go after state assets to secure its compensation.
- Pfizer Calls the Shots on Key Decisions – Pfizer decides delivery timeline and more.
In the event YouTube poofs the vid, here it is on Rumble———
Primetime Show in India Exposes How Pfizer Bullies and Blackmails Countries for Shots (rumble.com)
Pfizer Is Calling the Shots to Jab Kids (noqreport.com)
- Public Citizen has reviewed and published the secret contracts between Pfizer and Albania, Brazil, Colombia, Chile, Dominican Republic, the European Commission, Peru, the U.S. and the U.K. The contracts reveal nations have handed over unprecedented power to Pfizer, and in virtually all scenarios, Pfizer’s interests come first
- Some countries, including Brazil, Chile, Colombia, the Dominican Republic and Peru, have put up sovereign assets as collateral for vaccine injury lawsuits, including bank reserves, military bases and embassy buildings
- The contracts not only secure Pfizer’s intellectual property rights, but should Pfizer be found guilty of stealing the intellectual property rights of others, some of the contracts shift the responsibility onto the government purchasers. Pfizer can steal the intellectual property of others without consequence in at least four countries
- The contracts also give Pfizer the right to muzzle government. In Brazil, government officials are prohibited from making “any public announcement concerning the existence, subject matter or terms of [the] Agreement” without the written consent of the company. Similar nondisclosure provisions are included in the contracts with the European Commission and the U.S. government. The only difference is that the nondisclosure rules apply to both parties
- October 26, 2021, the U.S. Food and Drug Administration voted to extend the emergency use of Pfizer’s COVID jab for children aged 5 through 11. Experts warn this is reckless and unnecessary, and will do far more harm than good, as COVID-19 poses no risk to young children
G0ingBr0ke on Twitter: “@RWMaloneMD https://t.co/Trsy54OhZk” / Twitter
Staggering Conflicts of Interest
When you look at the roster of the FDA’s committee members who reviewed and voted to authorize the Pfizer shot for children as young as 5, the unanimous “yes” vote becomes less of a mystery. As reported by National File, they have staggering conflicts of interest. Members include:
- Gregg Sylvester — A former vice president of Pfizer Vaccines
- Arnold S. Monto — A paid Pfizer consultant
- Archana Chatterjee — A recent Pfizer research grant recipient
- Myron Levine — Mentor to Raphael Simon, senior director of vaccine research and development at Pfizer
- James Hidreth — President of Meharry Medical College, which administers Pfizer vaccines
- Geeta Swamy — Chair of the Independent Data Monitoring Committee for the Pfizer Group B Streptococcus Vaccine Program
- Steven Pergam — Proudly photographed taking a Pfizer vaccine
- Several people who are already on the record supporting coronavirus vaccines for children, including Ofer Levy, Jay Portnoy and Melinda Wharton
In addition to that, former FDA commissioner Scott Gottlieb is currently on Pfizer’s board of directors.
